Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Effect of a Low Starch Diet in Patients With Ankylosing Spondylitis
Universidade do Porto
Investigating Lysosomal Storage Diseases in Minority Groups
O & O Alpan LLC
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)
Definium Therapeutics US, Inc.
Milrinone Versus Dobutamine in Critically Ill Patients
Ottawa Heart Institute Research Corporation
Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy in People With Illness-related Anxiety
Multidisciplinary Association for Psychedelic Studies
The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy Volunteers
Psychiatric University Hospital, Zurich
A Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)
BioMarin Pharmaceutical
Comparative Acute Effects of LSD, Psilocybin and Mescaline
University Hospital, Basel, Switzerland
The "Motoric Cognitive Risk" Syndrome in the Quebec Population
Jewish General Hospital
Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA
Neutrolis
Personality and Drug Use
Psychedelic Data Society
Mood Effects of Serotonin Agonists: Depression
University of Chicago
The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training
Felix Mueller
Salivary Oxytocin as a Biomarker of Psychedelic Treatment
University of Geneva, Switzerland
Microdosing LSD in Women With Premenstrual Disorders
Friederike Holze
Role of the Serotonin 5-HT2A Receptor in LSD-induced Altered States of Consciousness (LDR-Study)
University Hospital, Basel, Switzerland
A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C
ZevraDenmark
Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)
BioMarin Pharmaceutical
Psychological, Physiological, Endocrine, and Pharmacokinetic Effects of LSD in a Controlled Study
University Hospital, Basel, Switzerland
LSD Treatment for Persons With Alcohol Use Disorder
Felix Mueller
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
Yale University
Drug Effects on Mood and Behavior - Expectancy
University of Chicago
Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD
University Hospital, Basel, Switzerland
Sodium Lactate and Brain Relaxation (LSD)
Centre Hospitalier Universitaire de Besancon
A Double-Blind Study to Evaluate the Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)
BioMarin Pharmaceutical
Brain Derived Neurotropic Factor Response to Aerobic Exercise Intensity in Depressive Patients.
St. Olavs Hospital
LSD Base and LSD Tartrate Bioequivalence and Bioavailability in Healthy Subjects
University Hospital, Basel, Switzerland
LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders
University Hospital, Basel, Switzerland
Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment
University Hospital, Geneva
A Phase 1 Study To Evaluate the Safety of Migalastat Hydrochloride Given Intravenously to Healthy Volunteers
Amicus Therapeutics
LSD Occupancy of the Serotonin 2A Receptor in the Human Brain
Rigshospitalet, Denmark
Salivary Oxytocin as a Biomarker in Psychedelic Assisted Psychotherapy
Tatiana Aboulafia Brakha
Safety and Efficacy of Low Dose MM-120 for ADHD Proof of Concept Trial
Definium Therapeutics US, Inc.
Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Lysergic Acid Diethylamide (LSD) in Palliative Care
University Hospital, Basel, Switzerland
Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache
University Hospital, Basel, Switzerland
Study of BMN 110 in Pediatric Patients < 5 Years of Age With Mucopolysaccharidosis IVA (Morquio A Syndrome)
BioMarin Pharmaceutical
Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome
BioMarin Pharmaceutical
Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion Processing
University Hospital, Basel, Switzerland
Personality and Drug Use (PDU)
Quantified Citizen Technologies Inc.
Effect of Ketanserin After LSD Administration
University Hospital, Basel, Switzerland
A Dose-Ranging Study of 50 µg to 100 µg LSD in Healthy Volunteers
Eleusis Therapeutics
Autologous Transplantation of Cultivated Limbal Stem Cells on Amniotic Membrane in Limbal Stem Cell Deficiency (LSD) Patients
Royan Institute
Stem Cell Gene Therapy for Cystinosis
University of California, San Diego
Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
A Dose-Finding Study of MM-120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms
Definium Therapeutics US, Inc.
LSD to Improve Cluster Headache Impact Trial
Radboud University Medical Center
Effects of MDMA Co-administration on the Response to LSD in Healthy Subjects
University Hospital, Basel, Switzerland
Cellular Pharmacodynamics of Small Molecules in Lysosomal Storage Disorders
Lysosomal and Rare Disorders Research and Treatment Center, Inc.
Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy Subjects
University Hospital, Basel, Switzerland
Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in Healthy Participants
University Hospital, Basel, Switzerland
Mood Effects of Serotonin Agonists Extended
University of Chicago
Neuronal Correlates of Altered States of Consciousness
University Hospital, Basel, Switzerland
Efficacy and Safety Study of BMN 110 for Morquio A Syndrome Patients Who Have Limited Ambulation
BioMarin Pharmaceutical
A Study to Evaluate the Safety, Tolerability and Efficacy of BMN 110 in Subjects With Mucopolysaccharidosis IVA
BioMarin Pharmaceutical
A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)
Definium Therapeutics US, Inc.
Safety, Tolerability, Ascending Dose and Dose Frequency Study of rhHNS Via an IDDD in MPS IIIA Patients
Shire
Mood Effects of Serotonin Agonists
University of Chicago
Effects of Hallucinogens and Other Drugs on Mood and Performance
Johns Hopkins University
LSD-Perceptual-Choice-Study
University Hospital, Basel, Switzerland
Effects of LSD on Neuroplasticity in Healthy Subjects
University of Fribourg
LSD Therapy for Persons Suffering From Major Depression
University Hospital, Basel, Switzerland
Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease
Shire
Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin
University Hospital, Basel, Switzerland
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)
Definium Therapeutics US, Inc.
The Effect of LSD on Neural Synchrony, Prosocial Behavior, and Relationship Quality
Maastricht University
Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects
University Hospital, Basel, Switzerland
MCR Syndrome in Quebec : Results From NuAge Study
Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal
A Clinical Assessment Study of Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome)
BioMarin Pharmaceutical
Pro-inflammatory Role of Blood Platelets in Critically Ill Patients With Septic Shock.
University Hospital, Bordeaux
A Double-blind, Placebo-controlled Study to Evaluate Very Low Dose LSD in Healthy Volunteers Aged 55-75 Years
Eleusis Therapeutics
BMN 110 US Expanded Access Program
BioMarin Pharmaceutical
Extension of Study HGT-SAN-055 Evaluating Administration of rhHNS in Patients With Sanfilippo Syndrome Type A (MPS IIIA)
Shire
How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
Read the trial details, eligibility criteria, and what participation involves.
Reach out to the study team using the contact information provided.
Complete the screening process to determine if you're eligible.